RankingsPricing
  1. US-listed companies
  2. GILEAD SCIENCES, INC.
  3. Financials
  4. Common stock and paid-in capital

GILEAD SCIENCES, INC.GILD

Market cap
$157.7B
P/E ratio
SummaryFinancials
Period EndCommon stock and paid-in capital (Million USD)YoY (%)
Dec 31, 20247,701+18.46%
Dec 31, 20236,501+17.11%
Dec 31, 20225,551+19.07%
Dec 31, 20214,662+20.12%
Dec 31, 20203,881+27.16%
Dec 31, 20193,052+33.68%
Dec 31, 20182,283+80.47%
Dec 31, 20171,265+178.02%
Dec 31, 2016455+2.25%
Dec 31, 2015445-81.40%
Dec 31, 20142,393-55.59%
Dec 31, 20135,388-4.53%
Dec 31, 20125,643+15.08%
Dec 31, 20114,904+5.48%
Dec 31, 20104,649

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)